Cutaneous T-Cell-Rich Lymphoid Infiltrates After SARS-CoV-2 Vaccination

Madeline J Hooper; Francesca L Veon; Tessa M LeWitt; Christopher Chung; Jaehyuk Choi; Xiaolong A Zhou; Joan Guitart

doi:10.1001/jamadermatol.2022.2383

Cutaneous T-Cell-Rich Lymphoid Infiltrates After SARS-CoV-2 Vaccination

JAMA Dermatol. 2022 Sep 1;158(9):1073-1076. doi: 10.1001/jamadermatol.2022.2383.

Authors

Madeline J Hooper¹, Francesca L Veon¹, Tessa M LeWitt¹, Christopher Chung¹, Jaehyuk Choi¹, Xiaolong A Zhou¹, Joan Guitart¹

Affiliation

¹ Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Abstract

This case series study describes cutaneous T-cell–rich lymphoid infiltrates characterized by papulonodules on the trunk and/or extremities in 6 patients after receiving the Pfizer/BioNTech COVID-19 mRNA vaccine.

MeSH terms

COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Humans
SARS-CoV-2
T-Lymphocytes*
Vaccination / adverse effects

Substances

COVID-19 Vaccines